ReviewAlzheimer's & dementia (New York, N. Y.)

Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.

Tuyet Thao Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.